Trial intelligence / Profile preview

Oral levothyroxine in healthy volunteers study

NL-OMON31212Not yet recruiting

Sponsor
Slotervaartziekenhuis
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of levothyroxine sodium, sponsored by Slotervaartziekenhuis. Primary endpoints: Prothrombin fragment 1+2, Von Willebrand factor antigen and 7 more. Planned start Jul 2007; status: not yet recruiting.

02

Drugs

levothyroxine sodium

Beyond the preview

Go deeper on NL-OMON31212.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31212.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call